Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Promoter methylation and tissue-specific transcription of the α7 nicotinic receptor gene, CHRNA7.

Canastar A, Logel J, Graw S, Finlay-Schultz J, Osborne C, Palionyte M, Drebing C, Plehaty M, Wilson L, Eyeson R, Leonard S.

J Mol Neurosci. 2012 Jun;47(2):389-400. doi: 10.1007/s12031-011-9663-7. Epub 2011 Nov 4.

PMID:
22052086
2.

Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Finlay-Schultz J, Canastar A, Short M, El Gazzar M, Coughlan C, Leonard S.

J Biol Chem. 2011 Dec 9;286(49):42123-32. doi: 10.1074/jbc.M111.276014. Epub 2011 Oct 6.

3.

alpha7 nicotinic receptor gene promoter polymorphisms in inbred mice affect expression in a cell type-specific fashion.

Mexal S, Jenkins PM, Lautner MA, Iacob E, Crouch EL, Stitzel JA.

J Biol Chem. 2007 May 4;282(18):13220-7. Epub 2007 Mar 14.

4.

Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.

Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, Drebing C, Berger R, Venn D, Sirota P, Zerbe G, Olincy A, Ross RG, Adler LE, Freedman R.

Arch Gen Psychiatry. 2002 Dec;59(12):1085-96.

PMID:
12470124
5.

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.

Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.

Mol Cancer. 2008 Nov 6;7:83. doi: 10.1186/1476-4598-7-83.

6.

Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.

Karius T, Schnekenburger M, Ghelfi J, Walter J, Dicato M, Diederich M.

Biochem Pharmacol. 2011 Jun 1;81(11):1329-42. doi: 10.1016/j.bcp.2011.03.014. Epub 2011 Mar 29.

PMID:
21453686
7.

[Relationship between RAR-beta gene expression defect and its methylation].

Gao YP, Li M, Zhang YY, Wang H, He XH, Wang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2007 Jul;42(7):472-6. Chinese.

PMID:
17961338
8.

Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.

Guarcello V, Blanquicett C, Naguib FN, El Kouni MH.

Cancer Chemother Pharmacol. 2008 Jun;62(1):85-96. Epub 2007 Sep 1.

PMID:
17805539
9.

Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.

Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.

Laryngoscope. 2005 Aug;115(8):1395-401.

PMID:
16094112
10.

DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.

Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.

Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):185-97. Epub 2006 Jul 11.

PMID:
17164146
11.

Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation.

Andria ML, Simon EJ.

Brain Res Mol Brain Res. 1999 Jun 18;70(1):54-65.

PMID:
10381543
12.

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.

Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.

Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30.

13.
14.

hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.

de Wilde J, Kooter JM, Overmeer RM, Claassen-Kramer D, Meijer CJ, Snijders PJ, Steenbergen RD.

BMC Cancer. 2010 Jun 9;10:271. doi: 10.1186/1471-2407-10-271.

15.

Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.

Li JY, Han C, Zheng LL, Guo MZ.

Chin Med J (Engl). 2012 Oct;125(19):3526-31.

PMID:
23044318
16.

Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.

Noetzel E, Rose M, Sevinc E, Hilgers RD, Hartmann A, Naami A, Knüchel R, Dahl E.

Oncogene. 2010 Aug 26;29(34):4814-25. doi: 10.1038/onc.2010.229. Epub 2010 Jun 14.

PMID:
20543860
17.
19.

The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.

Chen JT, Cheng YW, Chou MC, Sen-Lin T, Lai WW, Ho WL, Lee H.

Clin Cancer Res. 2003 Sep 15;9(11):4200-4.

20.

Mice deficient in CHRNA7, a subunit of the nicotinic acetylcholine receptor, produce sperm with impaired motility.

Bray C, Son JH, Kumar P, Meizel S.

Biol Reprod. 2005 Oct;73(4):807-14. Epub 2005 Jun 8.

PMID:
15944242

Supplemental Content

Support Center